Mysuru: Public Health Research Institute of India (PHRII) launched a new device called Enhanced Visual Assessment (EVA) colposcopy, a mobile colposcopy which supports the routine cervical cancer screening programme with visual inspection of cervix to identify pre-cancer lesion of cervix, at a programme organised at Rajendra auditorium in JSS Hospital premises here recently.
EVA device is fully portable and weighs only 605 gms and helps telecommunication with other providers. Each patient can immediately see images of their vagina and cervix. Providers can explain what they see and why they are recommending follow-up.
Dr. M. Dayananda, Director of JSS Hospital, Dr. M. Guruswamy, Medical Superintendent of JSS Hospital, Dr. G.V. Manjunatha, Vice-Principal, Dr. M.N. Suma, Vice-Principal of JSS Academy of Higher Education and Research, Dr. Anjali Arun, Managing Trustee of PHRII, Sasha, Global Health Equity Scholar of PHRII, Berkely University, were present as guests.
Dr. Dayananda and his team launched the EVA device. Guests addressed on the importance of cervical cancer screening and the partnership between JSS and PHRII.
Dr. Vijaya Srinivas, Senior Research Physician of PHRII, gave an update on cervical cancer in India and Shasha presented and demonstrated the EVA device.
For more information about EVA device, contact Dr. Vijaya Srinivas on Mob: 99862-85724.